Ekso BionicsEKSO
About: Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
Employees: 72
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
198% more capital invested
Capital invested by funds: $2.08M [Q2] → $6.2M (+$4.12M) [Q3]
13.91% more ownership
Funds ownership: 10.91% [Q2] → 24.82% (+13.91%) [Q3]
0% more funds holding
Funds holding: 28 [Q2] → 28 (+0) [Q3]
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Lake Street Ben Haynor 43% 1-year accuracy 3 / 7 met price target | 170%upside $2 | Buy Maintained | 29 Oct 2024 |
HC Wainwright & Co. Swayampakula Ramakanth 30% 1-year accuracy 48 / 159 met price target | 1,116%upside $9 | Buy Maintained | 29 Oct 2024 |
Financial journalist opinion
Based on 6 articles about EKSO published over the past 30 days
